LSE:HLN (Haleon plc)
About HLN
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health. Built on trusted science, innovation, and deep human understanding, Haleon's U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more.
Haleon plc (LSE: HLN) Latest News
Investing Articles
Are Haleon shares primed to soar after the demerger?
Investing Articles
Should I buy Haleon shares after the GSK spin-off?
❮2